Public Law 119-73 (01/23/2026)

subpart 8 fees relating to biosimilar biological products

Browse units

No subordinate units are indexed for this unit.

Sections

§ 379j–51 Definitions
§ 379j–52 Authority to assess and use biosimilar biological product fees
§ 379j–53 Reauthorization; reporting requirements